Skip to main content
Peripheral Nerve Blocks for Hip Fractures

JAMA reviews the use of peripheral nerve block with hip fractures as an effe

Dr. John Cush RheumNow

1 year 4 months ago
Peripheral Nerve Blocks for Hip Fractures JAMA reviews the use of peripheral nerve block with hip fractures as an effective pain management strategy that can be performed by credentialed clinicians outside of the operating room. https://t.co/baeLWVxeUo https://t.co/ZBTVDT0jGR
A comprehensive examination of the pathogenesis and recent advancements in Familial Mediterranean Fever (FMF). This cond

Dr. John Cush RheumNow

1 year 4 months ago
A comprehensive examination of the pathogenesis and recent advancements in Familial Mediterranean Fever (FMF). This condition results from autosomal recessive mutations in the MEFV gene, which codes for Pyrin, a crucial component of the NLRP3 inflammasome. These genetic https://t.co/XNV89LW893
A study in mice shows that JAK inhibition In mice model of status epilepticus (SE) didnt prevent initial SE but when did

Dr. John Cush RheumNow

1 year 4 months ago
A study in mice shows that JAK inhibition In mice model of status epilepticus (SE) didnt prevent initial SE but when did effect chronic phase of Sz weeks after SE induction of SE, suppressing seizures, and epilepsy-associated histopathological alterations. Sz suppression lasted https://t.co/GMIPCtoc7x
ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting n

ACR_Journals ACR_Journals

1 year 4 months ago
ACPA specificity and recognition motifs examined in 6,907 patients with RA from 5 Scandinavian cohorts. ACPA targeting non-glycine citrulline motifs assoc. more strongly w/ HLA-SE; ACPA to glycine citrulline motifs assoc. w/ smoking and IgA ACPA A&R https://t.co/PmKv3dZLc4 https://t.co/NdPG4Orfj4
Autoimmune Disease Impact Report

Integrated Benefit Institute, a nonprofit independent research organization, has publ

Dr. John Cush RheumNow

1 year 4 months ago
Autoimmune Disease Impact Report Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/TfXZti5NN3
Worse Outcomes in HLA-B27+ JIA
  • MedPage Today
Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.
Machine learning (ML) models were used to predict premature death in inflammatory bowel disease (IBD) patients with multimorbidity, the co-occurrence of 2 or more chronic conditions. 
Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since their approval, the indications for these medical drugs have steadily increased, but recently safety concerns have also been raised.
JAMA reviews the use of peripheral nerve block with hip fractures as an effective pain management strategy that can be performed by credentialed clinicians outside of the operating room.Hip fractures are common, especially in older adults (≥65 years), and may include a 1-year mortality rate of 12% to 25%. In the US, there were approximately 290 130 hospitalizations and 7731 deaths related to hip fractures in 2019. 
Dr. Swamy Venuturupalli, a Community Practice Innovation Award recipient, is transforming telehealth in rheumatology! Hi

Rheumatology Research Foundation RheumResearch

1 year 4 months ago
Dr. Swamy Venuturupalli, a Community Practice Innovation Award recipient, is transforming telehealth in rheumatology! His project introduces an innovative app that empowers patients to examine their own joints—making high-quality telehealth a seamless part of care. https://t.co/R5M4jtVz5m
#Thrombocytopenia is common in #antiphospholipid syndrome (APS), and is likely associated with more severe disease. Alth

Alberto Giraldo alb_giraldo

1 year 4 months ago
#Thrombocytopenia is common in #antiphospholipid syndrome (APS), and is likely associated with more severe disease. Although the pathophysiology underlying thrombocytopenia in APS has yet to be definitively revealed, mechanisms that play a role (at least in subsets of patients) https://t.co/pUXmb1irbw
THERE’S STILL TIME to join us for #SOTA25, April 4-6 in Chicago! Secure your seat TODAY for a weekend of #rheum educat

American College of Rheumatology ACRheum

1 year 4 months ago
THERE’S STILL TIME to join us for #SOTA25, April 4-6 in Chicago! Secure your seat TODAY for a weekend of #rheum education, connection, & innovation → https://t.co/DEmGVZO5Af https://t.co/1D2j2enA2X
Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases).

Eric Topol EricTopol

1 year 4 months ago
Of >105,000 participants with 30-year follow-up, only 9.3% achieved healthy aging (age 70, w/o any chronic diseases). Their diet was significantly associated with this outcome🧵 @NatureMedicine https://t.co/VHxmdLvoDe
• Don't be afraid of being different.
• Take risks.
• Be curious.
• Don't be afraid to fail.
• Work hard for t

Prof. Feynman ProfFeynman

1 year 4 months ago
• Don't be afraid of being different. • Take risks. • Be curious. • Don't be afraid to fail. • Work hard for the things you love the most. https://t.co/7OeB5WfnNy
×